Ikena Oncology, INC Form 4 insider transactions

Director Iain D. Dukes acquired 17,520 stock options in Ikena Oncology, Inc. on June 7, 2024.

Director Owen Hughes acquired 17,520 stock options in Ikena Oncology, Inc. on June 7, 2024, at an exercise price of $1.75.

Director Maria Koehler reports acquisition of stock options in Ikena Oncology.

Director Otello Stampacchia reports acquisition of stock options in Ikena Oncology, Inc.

Caroline Germa, Chief Medical Officer of Ikena Oncology, acquired stock options for 579,100 shares on March 1, 2024, according to a Form 4 filing.